BC Centre for Excellence in HIV/AIDS

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment and education facility and is internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases. BC-CfE is based at St. Paul’s Hospital, Providence Health Care, a teaching hospital of the University of British Columbia. The BC-CfE works in close collaboration with key provincial stakeholders, including health authorities, health care providers, academics from other institutions, and the community to decrease the health burden of HIV and AIDS and to improve the health of British Columbians living with HIV through developing, monitoring and disseminating comprehensive research and treatment programs for HIV and related illnesses.

[bc-cfe]

Dr. Julio Montaner is a leader in the movement for early HIV treatment. People are living longer, healthier lives. Vancouver’s proactive scale-up and innovative service delivery of HIV testing and treatment is hailed as a reference of the cost-benefits of HIV treatment expansion. Its approach is now being emulated in countries and localities worldwide as a successful model in the AIDS response.

[bc-cfe]

New research broadens case for early treatment http://bit.ly/1F1e0S9

[bc-cfe]

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will In 1996, the global HIV community gathered in Vancouver, Canada, for the XI International AIDS Conference and shared the clear evidence that triple-combination antiretroviral treatment held the power to stem the tide of deaths from AIDS. The HIV treatment era had begun. As we gathered again in Vancouver in July, 2015, it was clear that a new transformative moment is upon us. The Vancouver Consensus statement,1 which emerged at the recently concluded 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), signals the scientific affirmation that, rather than limiting access to those who are immune compromised, immediate access to antiretroviral medicines holds the power to rapidly advance the fight to end AIDS.

[bc-cfe]

Read the latest issue of Forecast - The Journal of the BC Centre for Excellence in HIV/AIDS http://bit.ly/1VlJlpI

[bc-cfe]

Made-in-Canada HIV/AIDS treatment embraced by everyone but Canada

A made-in-Canada approach to tackling the HIV/AIDS epidemic has been endorsed by the United Nations for use around the world but has yet to gain the support of the Canadian government. Read the story here: glbn.ca/SX2A8

[bc-cfe]

Dr Julio Montaner met with Assembly of First Nations National Chief Perry Bellegarde, they discussed the Treatment as Prevention strategy to help STOP HIV in First Nations communities across the country.

Following the meeting, Dr. Montaner presented Chief Bellegarde a Tiko Kerr print of St. Paul's Hospital, as a warm gift of friendship.

[bc-cfe]

Celebrating HIV Research and Results: Treatment as Prevention

October 27, 2015, 10:00 am - 3:00 pm

[bc-cfe]

Life expectancy of #HIV-positive individuals on combination antiretroviral therapy in Canada http://bit.ly/1MejKZs  

[bc-cfe]

Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study http://ht.ly/SiMJE

[bc-cfe]

Forecast -  Journal of the BC Centre for Excellence in HIV/AIDS

Read it on line here: http://bit.ly/1Ng6N1s

[bc-cfe]

Achieving an AIDS-free World: What will it take? Dr. Julio Montaner on TasP and 90-90-90 target

[bc-cfe]

(via https://www.youtube.com/watch?v=_yG6tDMHAXg)

Watch Dr. Zunyou Wu speak on China taking action Toward 90-90-90 Target

[bc-cfe]

Watch Dr. Julio Montaner speak on 90–90–90: An ambitious treatment target to help end the AIDS epidemic By 2020, 90% of all people living with HIV will know their HIV status. By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy. By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression.

[bc-cfe]

Dr. Julio Montaner on the Last 20 Years in HIV Research

[bc-cfe]

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will

In 1996, the global HIV community gathered in Vancouver, Canada, for the XI International AIDS Conference and shared the clear evidence that triple-combination antiretroviral treatment held the power to stem the tide of deaths from AIDS. The HIV treatment era had begun. As we gathered again in Vancouver in July, 2015, it was clear that a new transformative moment is upon us. The Vancouver Consensus statement,1 which emerged at the recently concluded 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), signals the scientific affirmation that, rather than limiting access to those who are immune compromised, immediate access to antiretroviral medicines holds the power to rapidly advance the fight to end AIDS.

Read more: http://bit.ly/1Dvywtj

[bc-cfe]

Achieving an AIDS-free World: What will it take? Dr. Julio Montaner on TasP and 90-90-90 target

[bc-cfe]

HIV rates in vulnerable men to be studied with $6.5M grant

A SFU researcher is receiving a $6.5 million grant for his study on HIV rates among men who have sex with men.